Literature DB >> 13377660

Treatment of Hodgkin's granuloma, chronic lymphatic leukaemia, polycythaemia vera, and other reticuloses with triethylenethiophosphoramide.

M C ISRAELS, B J LEONARD, J F WILKINSON.   

Abstract

Entities:  

Keywords:  CYTOTOXIC DRUGS/therapeutic use; HODGKINS DISEASE/therapy; POLYCYTHEMIA VERA/therapy; SARCOMA, RETICULUM CELL/therapy

Mesh:

Substances:

Year:  1956        PMID: 13377660     DOI: 10.1016/s0140-6736(56)90268-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Mannomustine in treatment of leukaemias, polycythaemia, and malignant disorders.

Authors:  A M BARLOW; J T LEEMING; J F WILKINSON
Journal:  Br Med J       Date:  1959-08-22

Review 2.  Cancer chemotherapy--the first twenty-five years.

Authors:  R B Scott
Journal:  Br Med J       Date:  1970-10-31

3.  Dosing of thioTEPA for myeloablative therapy.

Authors:  D Przepiorka; T Madden; C Ippoliti; Z Estrov; M Dimopoulos
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

4.  Treatment of leukaemias and reticuloses with uracil mustard.

Authors:  J F WILKINSON; M S BOURNE; M C ISRAELS
Journal:  Br Med J       Date:  1963-06-15

5.  Triethylene thiophosphoramide in the treatment of previously hypophysectomised patients with carcinoma of the breast.

Authors:  K J GURLING
Journal:  Br J Cancer       Date:  1959-06       Impact factor: 7.640

6.  Effect of Thio-TEPA on advanced malignant ovarian tumours.

Authors:  O ENGLANDER; A SARANGI
Journal:  Br J Cancer       Date:  1960-03       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.